UB Paderborn / Katalog / Suche / in CDI

Stereotactic body radiation therapy (SBRT) on renal cell carcinoma, an overview of technical aspects, biological rationale and current literature

Critical reviews in oncology/hematology, 2018-11, Vol.131, p.24-29

2018

Volltextzugriff (PDF)

Stereotactic Body Radiation Therapy in the Management of Oligometastatic and Oligoprogressive Bladder Cancer and Other Urothelial Malignancies

Clinical oncology (Royal College of Radiologists (Great Britain)), 2021-01, Vol.33 (1), p.50-56

2021

Volltextzugriff (PDF)

In Reply to Guler and Onal

Clinical oncology (Royal College of Radiologists (Great Britain)), 2022-01, Vol.34 (1), p.e84-e85

2022

Volltextzugriff (PDF)

Toxicity after moderately hypofractionated versus conventionally fractionated prostate radiotherapy: A systematic review and meta-analysis of the current literature

Critical reviews in oncology/hematology, 2021-09, Vol.165, p.103432-103432, Article 103432

2021

Volltextzugriff (PDF)

Impact of COVID-19 on patient–doctor interaction in a complex radiation therapy facility

Supportive care in cancer, 2021-06, Vol.29 (6), p.2931-2937

2021

Volltextzugriff (PDF)

Robotic Stereotactic Retreatment for Biochemical Control in Previously Irradiated Patients Affected by Recurrent Prostate Cancer

Clinical oncology (Royal College of Radiologists (Great Britain)), 2018-02, Vol.30 (2), p.93-100

2018

Volltextzugriff (PDF)

Correction to: Impact of COVID-19 on patient–doctor interaction in a complex radiation therapy facility

Supportive care in cancer, 2022-02, Vol.30 (2), p.1891-1892

2022

Volltextzugriff (PDF)

Stereotactic ablative radiotherapy in castration-resistant prostate cancer patients with oligoprogression during androgen receptor-targeted therapy

Clinical & translational oncology, 2021-08, Vol.23 (8), p.1577-1584

2021

Volltextzugriff (PDF)

Pattern of Recurrence After Stereotactic Radiotherapy in Prostate Cancer Patients With Nodal Pelvic Relapse. A Multi-Institutional Retrospective Analysis

Clinical oncology (Royal College of Radiologists (Great Britain)), 2022-01, Vol.34 (1), p.57-62

2022

Volltextzugriff (PDF)

Stereotactic Re-irradiation in Recurrent Prostate Cancer after Previous Postoperative or Definitive Radiotherapy: Long-term Results after a Median Follow-up of 4 Years

Clinical oncology (Royal College of Radiologists (Great Britain)), 2022-01, Vol.34 (1), p.50-56

2022

Volltextzugriff (PDF)

Tumor-associated macrophages (TAMs) modulate response to HER2-targeted agents in a humanized mouse model of breast cancer

Clinical & translational oncology, 2022-07, Vol.24 (7), p.1395-1402

2022

Volltextzugriff (PDF)

In reply to: Anti-HER2 neoadjuvant treatment may have an impact on discordance between preoperative core needle biopsy and surgical specimen in early breast cancer

European journal of surgical oncology, 2017-06, Vol.43 (6), p.1143-1144

2017

Volltextzugriff (PDF)

Postoperative radiotherapy after upfront radical prostatectomy: debated issues at a turning point—a survey exploring management trends on behalf of AIRO (Italian Association of Radiotherapy and Clinical Oncology)

Clinical & translational oncology, 2021-12, Vol.23 (12), p.2568-2578

2021

Volltextzugriff (PDF)

Benefit of ablative versus palliative-only radiotherapy in combination with nivolumab in patients affected by metastatic kidney and lung cancer

Clinical & translational oncology, 2019-07, Vol.21 (7), p.933-938

2019

Volltextzugriff (PDF)

Detection rate, pattern of relapse and influence on therapeutic decision of PSMA PET/CT in patients affected by biochemical recurrence after radical prostatectomy, a retrospective case series

Clinical & translational oncology, 2021-02, Vol.23 (2), p.364-371

2021

Volltextzugriff (PDF)

Gamma Knife Radiosurgery in the management of single and multiple brain metastases

Clinical neurology and neurosurgery, 2016-02, Vol.141, p.43-47

2016

Volltextzugriff (PDF)

Radiotherapy is effective in the management of rare penile metastases: Two case reports

Cancer radiothérapie, 2021-07, Vol.25 (5), p.480-483

2021

Volltextzugriff (PDF)

BRCA1/2 mutation in breast cancer: biological aspects, patterns of care and impact on outcome in a monoinstitutional cohort

European journal of cancer (1990), 2017-02, Vol.72, p.S19-S19

2017

Volltextzugriff (PDF)

Impact of sentinel node tumor burden on outcome of invasive breast cancer patients

European journal of surgical oncology, 2014-10, Vol.40 (10), p.1195-1202

2014

Volltextzugriff (PDF)

Metastasis-directed Stereotactic Body Radiotherapy (SBRT)-guided by pet-ct 18f-choline versus pet-ct 68ga-psma in castration sensitive oligorecurrent prostate cancer: A comparative effectiveness analysis

European urology open science (Online), 2020-11, Vol.21, p.S140

2020

Volltextzugriff (PDF)

PO-0807: Radiosurgery and brain metastases: high-resolution MRI can significantly change intracranial disease staging

Radiotherapy and oncology, 2015-04, Vol.115, p.S405-S405

2015

Volltextzugriff (PDF)

Early results from a phase II randomized trial testing stereotactic body radiation therapy in patients with oligometastatic castration resistant prostate cancer undergoing I line treatment with abiraterone acetate (ARTO trial-NCT03449719)

European urology open science (Online), 2020-11, Vol.21, p.S150

2020

Volltextzugriff (PDF)

EP-1357: GammaKnife Radiosurgery in the management of single and multiple brain metastases

Radiotherapy and oncology, 2015-04, Vol.115, p.S731-S732

2015

Volltextzugriff (PDF)

Stereotactic radiotherapy in oligoprogressive and oligorecurrent urothelial cancer patients: A retrospective experience

Cancer treatment and research communications, 2019, Vol.19, p.100124-100124, Article 100124

2019

Volltextzugriff (PDF)

Differences in the Effect of Angiotensin-converting Enzyme Inhibitors on the Rate of Endothelial Cell Apoptosis : In Vitro and In Vivo Studies

Cardiovascular drugs and therapy, 2007-12, Vol.21 (6), p.423-429

2007

Volltextzugriff (PDF)

Menü

Weitere Dienste

Einstellungen

Stereotactic body radiation therapy (SBRT) on renal cell carcinoma, an overview of technical aspects, biological rationale and current literature

Stereotactic Body Radiation Therapy in the Management of Oligometastatic and Oligoprogressive Bladder Cancer and Other Urothelial Malignancies

In Reply to Guler and Onal

Toxicity after moderately hypofractionated versus conventionally fractionated prostate radiotherapy: A systematic review and meta-analysis of the current literature

Impact of COVID-19 on patient–doctor interaction in a complex radiation therapy facility

Robotic Stereotactic Retreatment for Biochemical Control in Previously Irradiated Patients Affected by Recurrent Prostate Cancer

Correction to: Impact of COVID-19 on patient–doctor interaction in a complex radiation therapy facility

Stereotactic ablative radiotherapy in castration-resistant prostate cancer patients with oligoprogression during androgen receptor-targeted therapy

Pattern of Recurrence After Stereotactic Radiotherapy in Prostate Cancer Patients With Nodal Pelvic Relapse. A Multi-Institutional Retrospective Analysis

Stereotactic Re-irradiation in Recurrent Prostate Cancer after Previous Postoperative or Definitive Radiotherapy: Long-term Results after a Median Follow-up of 4 Years

Tumor-associated macrophages (TAMs) modulate response to HER2-targeted agents in a humanized mouse model of breast cancer

In reply to: Anti-HER2 neoadjuvant treatment may have an impact on discordance between preoperative core needle biopsy and surgical specimen in early breast cancer

Postoperative radiotherapy after upfront radical prostatectomy: debated issues at a turning point—a survey exploring management trends on behalf of AIRO (Italian Association of Radiotherapy and Clinical Oncology)

Benefit of ablative versus palliative-only radiotherapy in combination with nivolumab in patients affected by metastatic kidney and lung cancer

Detection rate, pattern of relapse and influence on therapeutic decision of PSMA PET/CT in patients affected by biochemical recurrence after radical prostatectomy, a retrospective case series

Gamma Knife Radiosurgery in the management of single and multiple brain metastases

Radiotherapy is effective in the management of rare penile metastases: Two case reports

BRCA1/2 mutation in breast cancer: biological aspects, patterns of care and impact on outcome in a monoinstitutional cohort

Impact of sentinel node tumor burden on outcome of invasive breast cancer patients

Metastasis-directed Stereotactic Body Radiotherapy (SBRT)-guided by pet-ct 18f-choline versus pet-ct 68ga-psma in castration sensitive oligorecurrent prostate cancer: A comparative effectiveness analysis

PO-0807: Radiosurgery and brain metastases: high-resolution MRI can significantly change intracranial disease staging

Early results from a phase II randomized trial testing stereotactic body radiation therapy in patients with oligometastatic castration resistant prostate cancer undergoing I line treatment with abiraterone acetate (ARTO trial-NCT03449719)

EP-1357: GammaKnife Radiosurgery in the management of single and multiple brain metastases

Stereotactic radiotherapy in oligoprogressive and oligorecurrent urothelial cancer patients: A retrospective experience

Differences in the Effect of Angiotensin-converting Enzyme Inhibitors on the Rate of Endothelial Cell Apoptosis : In Vitro and In Vivo Studies

Suchergebnisse filtern